Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Envirotainer and Swiss WorldCargo Complete the First Commercial Shipment Using the New Releye® RAP
Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, […]
Zeta Surgical Raises $5.2M in Seed Financing to Enhance Surgical Navigation with Robotics and Mixed Reality
Zeta Surgical, a surgical robotics and mixed reality company, announced today the close of a $5.2M financing […]
Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development
Promega Corporation (Promega), a leader in providing innovative solutions and technical support to the life sciences industry, […]
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
AbbVie (NYSE: ABBV) and Gedeon Richter Plc. (‘Richter’) today announced a new co-development and license […]
Orexo Appoints Fredrik Järrsten as New CFO
Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company has appointed Fredrik Järrsten as […]
Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-oncology
Domain Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting […]
Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines
Novo Nordisk today announced the expansion of its existing research collaboration in oral drug delivery […]
Fluent BioSciences Awarded $1.7 Million SBIR Grant to Commercialize PIPseq™, a Breakthrough Platform Technology Enabling Scalable, Sensitive Single-cell Analysis in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases
Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the […]
Exosome-based Company Raised 5 M€ for the Development of Its New Biomedicine and Vaccines
Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more